Literature DB >> 32701602

Actions of immune cells in the hypertensive kidney.

Xiaohan Lu1, Steven D Crowley.   

Abstract

PURPOSE OF REVIEW: Inflammatory processes play a critical role in the pathogenesis of hypertension. Innate and adaptive immune responses participate in blood pressure (BP) elevation and end-organ damage. In this review, we discuss recent studies illustrating mechanisms through which immune cells and cytokines regulate BP via their actions in the kidney. RECENT
FINDINGS: Cells of the innate immune system, including monocytes, neutrophils, and dendritic cells, can all promote BP elevation via effects on kidney function. These innate immune cells can directly impact oxidative stress and cytokine generation in the kidney and/or present antigens to lymphocytes for the engagement of the adaptive immune system. Once activated by dendritic cells, effector memory T cells accumulate in the hypertensive kidney and facilitate renal salt and water retention. Individual subsets of activated T cells can secrete tumor necrosis factor-alpha (TNF-α), interleukin-17a (IL-17a), and interferon-gamma (IFN-γ), each of which has augmented the elevation of blood pressure in hypertensive models by enhancing renal sodium transport. B cells, regulate blood pressure via vasopressin receptor 2 (V2R)-dependent effects on fluid transport in the kidney.
SUMMARY: Immune cells of the innate and adaptive immune systems drive sodium retention and blood pressure elevation in part by altering renal solute transport.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32701602      PMCID: PMC7732208          DOI: 10.1097/MNH.0000000000000635

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   3.416


  98 in total

1.  T regulatory lymphocytes prevent aldosterone-induced vascular injury.

Authors:  Daniel A Kasal; Tlili Barhoumi; Melissa W Li; Naoki Yamamoto; Evguenia Zdanovich; Asia Rehman; Mario F Neves; Pascal Laurant; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2011-12-05       Impact factor: 10.190

2.  Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice.

Authors:  Modar Kassan; Maria Galan; Megan Partyka; Mohamed Trebak; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

3.  Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension.

Authors:  H Haller; J K Park; D Dragun; A Lippoldt; F C Luft
Journal:  Nephrol Dial Transplant       Date:  1997-05       Impact factor: 5.992

4.  Inflammation and Hypertension: Causal or Not?

Authors:  Dave L Dixon; George F Wohlford; Antonio Abbate
Journal:  Hypertension       Date:  2019-12-30       Impact factor: 10.190

5.  Rag1-null Dahl SS rats reveal that adaptive immune mechanisms exacerbate high protein-induced hypertension and renal injury.

Authors:  Justine M Abais-Battad; Hayley Lund; Daniel J Fehrenbach; John Henry Dasinger; David L Mattson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-14       Impact factor: 3.619

6.  Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension.

Authors:  N E Rhaleb; H Peng; X P Yang; Y H Liu; D Mehta; E Ezan; O A Carretero
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

7.  Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension.

Authors:  L E Bautista; L M Vera; I A Arenas; G Gamarra
Journal:  J Hum Hypertens       Date:  2005-02       Impact factor: 3.012

8.  CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice.

Authors:  Hong-Xia Wang; Wen-Jun Li; Cui-Liu Hou; Song Lai; Yun-Long Zhang; Cui Tian; Hui Yang; Jie Du; Hui-Hua Li
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

9.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

10.  Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk: A Secondary Analysis of CANTOS.

Authors:  Alexander Mk Rothman; Jean MacFadyen; Tom Thuren; Alastair Webb; David G Harrison; Tomasz J Guzik; Peter Libby; Robert J Glynn; Paul M Ridker
Journal:  Hypertension       Date:  2019-12-30       Impact factor: 10.190

View more
  1 in total

Review 1.  Should Renal Inflammation Be Targeted While Treating Hypertension?

Authors:  Sarika Chaudhari; Grace S Pham; Calvin D Brooks; Viet Q Dinh; Cassandra M Young-Stubbs; Caroline G Shimoura; Keisa W Mathis
Journal:  Front Physiol       Date:  2022-06-13       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.